FISH VET GROUP LIMITED
PHARMAQ AS, operating as Fish Vet Group in the UK, is a Norwegian aquaculture health company and Zoetis subsidiary that develops vaccines, vaccination equipment, and diagnostic services for global salmonid, tilapia, pangasius, and sea bass farmers.
- Company typePrivate
- Founded1986
- HeadquartersOverhalla, Norway
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What FISH VET GROUP LIMITED does
PHARMAQ AS, operating commercially under the brand Fish Vet Group in the United Kingdom, is a Norwegian animal-health company specializing in aquaculture, founded in 1986 and headquartered in Overhalla, Norway. It is a wholly-owned subsidiary of Zoetis, the world leader in animal health, having been acquired in 2020, and operates globally through seven regional subsidiaries in Chile, the United Kingdom, Vietnam, Turkey, Spain, Panama, and Hong Kong. The company employs approximately 300–420 people worldwide and delivered an estimated 2 billion fish vaccine doses in 2025, supported by 39 years of dedicated R&D.
The company operates a three-pillar product platform under the sub-brands PHARMAQ, Fishteq, and Analytiq. PHARMAQ develops and supplies vaccines and therapeutics for salmonids, tilapia, pangasius, sea bass, and cleaner fish. Fishteq manufactures vaccination equipment including Micro-Matic syringes and vaccination machines, and provides professional vaccination services. Analytiq offers advanced diagnostic services — Real-time RT-PCR, histopathology, SmoltVision, microbiology, NGS, and data analytics — along with consultancy and training, with results accessible through the iWISE Customer Health Portal.
The business model is B2B enterprise sales-led, with quote-based, non-publicly disclosed pricing targeting aquaculture operators globally. Primary customers are salmonid farmers, with secondary segments in warm-water species and equipment operators. Revenue is generated through one-time sales of vaccines and therapeutics, hardware sales of vaccination machinery, and professional diagnostic and vaccination services. Marketing and distribution rely on direct sales, regional subsidiaries, industry events, digital content, and the iWISE customer portal.
FISH VET GROUP LIMITED firmographics
Firmographics- Name
- FISH VET GROUP LIMITED
- Legal name
- PHARMAQ AS
- Website
- https://fishvetgroup.com
- Company type
- Private
- Founded year
- 1986
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PHARMAQ AS, operating as Fish Vet Group in the UK, is a Norwegian aquaculture health company and Zoetis subsidiary that develops vaccines, vaccination equipment, and diagnostic services for global salmonid, tilapia, pangasius, and sea bass farmers.
- Ownership category
- akta.pro rank
FISH VET GROUP LIMITED industry classification
Industry- Product category
- Aquaculture Health Products
- NAICS
- Aquaculture (1125), Veterinary Services (54194)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Aquaculture Health, Biosecurity & Veterinary Services (AFAEAAAK)
- akta.pro secondary industries
- Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK), Aquaculture & Fish Health Services (AFAEANAE)
Keywords
Where FISH VET GROUP LIMITED is headquartered
LocationHeadquarters
- HQ city
- Overhalla
- HQ country
- Norway
- HQ region
- Europe
Offices9 records
Markets served
FISH VET GROUP LIMITED business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Vaccines and Therapeutics Products: Sale of fish health vaccines and therapeutic products to aquaculture companies globally
- Vaccination Equipment: Sale and service of vaccination machinery including machines and syringes
- Diagnostic Services: Laboratory diagnostic services including Real-time RT-PCR, histopathology, microbiology, NGS, and data analytics
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
FISH VET GROUP LIMITED product offering
Product offeringCore offering
FISH VET GROUP LIMITED operates the PHARMAQ aquaculture health business, developing, manufacturing, and selling fish vaccines and therapeutics for species including salmonids, tilapia, pangasius, sea bass, and cleaner fish. It also produces vaccination equipment (Micro-Matic syringes and vaccination machines), provides professional vaccination services, and runs a diagnostics laboratory offering Real-time RT-PCR, Histopathology, SmoltVision, Microbiology, NGS, data analytics, and consultancy to fish farmers globally.
Product overview
PHARMAQ operates as a multi-brand platform for aquaculture health solutions, comprising three main product lines: PHARMAQ (vaccines and therapeutics), FISHTEQ (vaccination equipment and services), and ANALYTIQ (diagnostics and data analytics). The company is the global leader in aquaculture vaccines, delivering approximately 2 billion fish vaccine doses annually, and offers a comprehensive portfolio spanning vaccine development, vaccination machinery, and advanced diagnostic services including Real-time RT-PCR, Histopathology, SmoltVision, Microbiology, NGS, and Data Analytics. PHARMAQ is a subsidiary of Zoetis, the world leader in animal health.
Differentiator
Problem solved
Functional benefit
Brands
- PHARMAQ: Vaccines and therapeutics for aquaculture - global leader in vaccine development and innovation
- Fishteq
- Analytiq
Products and services
- PHARMAQ Vaccines and Therapeutics
Quantifiable outcome
- 2 billion fish vaccine doses delivered in 2025
- +1 more outcomes
Companies that use FISH VET GROUP LIMITED
Customer profileSegments3 records
Ideal customer profiles3 records
FISH VET GROUP LIMITED technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
FISH VET GROUP LIMITED partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ZoetiscorePHARMAQ is part of Zoetis, the world leader in animal health. Zoetis is the parent company providing global scale and resources for the aquaculture health business unit.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
FISH VET GROUP LIMITED competitors and assessment
Company assessmentBroad incumbents
- Virbac: Independent global animal health company offering vaccines, diagnostics, and pharmaceuticals for both companion and production animals including aquaculture. Competes with PHARMAQ in select species and markets.
- Elanco Animal Health: Global animal health company with portfolio across companion and production animals, including aquaculture-relevant products. Larger incumbent with broader species coverage; competes with Zoetis/PHARMAQ across animal health broadly.
- MSD Animal Health: Division of Merck offering vaccines, parasiticides, and health management tools across multiple species including aquaculture. Shares the aquaculture vaccines market with PHARMAQ and competes on R&D breadth and global distribution.
Direct peers
- Hipra: Spanish animal health company with a dedicated aquaculture health business developing vaccines and therapeutics for farmed fish. Direct competitor to PHARMAQ in aquaculture vaccines, particularly in warm-water species and Mediterranean markets.
- Ceva Santé Animale: Global animal health company headquartered in France with aquaculture vaccines and therapeutics as a core focus. Direct competitor in fish vaccines and a comparable challenger in the aquaculture health segment.
- Benchmark Holdings: UK-based aquaculture biotechnology company providing salmon breeding, health, and nutrition solutions. Overlaps with PHARMAQ in aquaculture health services and genetics, though its primary focus is breeding and的营养 rather than vaccines.
Others
- Skretting: Global aquaculture feed producer owned by Nutreco. Adjacent rather than directly competing; its customer base overlaps with PHARMAQ's, enabling potential partnership and cross-selling opportunities in fish health.
- Cargill Aqua Nutrition: Aquaculture feed division of Cargill serving salmon, shrimp, and other farmed species. Adjacent rather than directly competing; serves the same aquaculture customers as PHARMAQ and is a potential channel partner for integrated health offerings.
Emerging players
- AquaBounty Technologies: Aquaculture biotech company focused on genetically engineered salmon for faster growth. Different product category (genetics vs. health) but operates in the same salmonid aquaculture ecosystem and shares the same customer base as PHARMAQ.
Regional players
- AquaGen: Norway-based aquaculture breeding company supplying salmon and trout eggs with health and genetic selection emphasis. Adjacent to PHARMAQ's salmonid health focus and based in the same core market, but sells breeding stock rather than health products.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
FISH VET GROUP LIMITED social profiles
Digital presenceFISH VET GROUP LIMITED financial estimates
Financial estimateRevenue estimate
Valuation estimate
FISH VET GROUP LIMITED leadership team
Management profileNumber of profiles
FISH VET GROUP LIMITED subsidiaries and ownership
Company hierarchySubsidiaries7 records
FISH VET GROUP LIMITED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FISH VET GROUP LIMITED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FISH VET GROUP LIMITED
What does FISH VET GROUP LIMITED do?
FISH VET GROUP LIMITED operates the PHARMAQ aquaculture health business, developing, manufacturing, and selling fish vaccines and therapeutics for species including salmonids, tilapia, pangasius, sea bass, and cleaner fish. It also produces vaccination equipment (Micro-Matic syringes and vaccination machines), provides professional vaccination services, and runs a diagnostics laboratory offering Real-time RT-PCR, Histopathology, SmoltVision, Microbiology, NGS, data analytics, and consultancy to fish farmers globally.
Is FISH VET GROUP LIMITED a public or private company?
FISH VET GROUP LIMITED is a private company. It is classified as corporate owned and is currently operating.
When was FISH VET GROUP LIMITED founded?
FISH VET GROUP LIMITED was founded in 1986. It employs 11 to 50 people.
Where is FISH VET GROUP LIMITED based?
FISH VET GROUP LIMITED is headquartered in Overhalla, Norway, in the Europe region.
How does FISH VET GROUP LIMITED make money?
Three revenue lines are on record. Vaccines and Therapeutics Products are the primary driver. The others are vaccination Equipment and diagnostic Services.
Who are FISH VET GROUP LIMITED's main competitors?
Broad incumbents on record are Virbac, Elanco Animal Health and MSD Animal Health. Direct peers are Hipra, Ceva Santé Animale and Benchmark Holdings. Others are Skretting and Cargill Aqua Nutrition. AquaBounty Technologies is listed as an emerging player. AquaGen is listed as a regional player.
Does FISH VET GROUP LIMITED have an API?
No public API is recorded for FISH VET GROUP LIMITED.
What industry is FISH VET GROUP LIMITED in?
FISH VET GROUP LIMITED's product category is Aquaculture Health Products. Its primary akta.pro industry code is AFAEAAAK, Aquaculture Health, Biosecurity & Veterinary Services, with a secondary code of AFAEANAK, Veterinary Pharmacy, Vaccine & Biologics Services. Its NAICS code is 1125 and its SIC code is 2834.